LYCOS RETRIEVER 
Onyx: United States
built 201 days ago
Onyx's subsequent Quarterly Reports on Form 10-Q for a more detailed description of such factors. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date of this release. Onyx undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date of this release except as required by law.
Source:
"The incidence of liver cancer continues to rise in the United States and around the world, highlighting the significant need for new therapies," said Hank Fuchs, executive vice president and chief medical officer of Onyx. "Our comprehensive development program continues to identify new areas where Nexavar's unique combination of multi-targeted activity, tolerability and oral dosing may meet additional unmet needs in cancer."
Source:
In the United States, MTI is conducting pivotal clinical trials for the use of Onyx in the treatment of brain aneurysms and AVMs. In Europe, MTI has received CE Mark to commercially promote Onyx for use in the treatment of aneurysms, AVMs, tumor embolization and certain peripheral applications. Worldwide, across all therapies, Onyx has been used in approximately 900 procedures.
Source:
MORE ABOUT
United States